As of 06 Nov 2026 12:49 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from the latest notice (28 Jul 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Trifluoperazine 1mg/5ml syrupaffected product · inferred from phrasing | Out of stock, as stated | April 2021precision: a month · window end 30 Apr 2021, derived from “April 2021” | notice of 28 Jul 2021 |
| Trifluoperazine 1mg and 5mg tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 28 Jul 2021 |
| Trifluoperazine 5mg/5ml oral solutionnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 28 Jul 2021 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Trifluoperazine 1mg and 5mg tablets — named by the source as remaining available (inferred from phrasing)
- Trifluoperazine 5mg/5ml oral solution — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Trifluoperazine
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 28 Jul 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 28 Jul 2021 | Medicine Supply Notification: Trifluoperazine 1mg/5ml syrup (Advanz Pharma) - Update | Supply notification | — | — |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2020)112 Trifluoperazine 1mg/5ml syrup (Advanz Pharma) · issued 17 Nov 2020 · valid until April 2021, as stated · matched by name PDF ↗